BMRP is a Bcl-2 binding protein that induces apoptosis

被引:37
|
作者
Chintharlapalli, SR
Jasti, M
Malladi, S
Parsa, KVL
Ballestero, RP
González-García, M
机构
[1] Texas A&M Univ, Dept Chem, Kingsville, TX 78363 USA
[2] Texas A&M Univ, Dept Biol, Kingsville, TX 78363 USA
关键词
Bcl-2; apoptosis; BMRP; mitochondria; ribosome; yeast Two-Hybrid screen;
D O I
10.1002/jcb.20292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the Bcl-2 family of proteins play important roles in the regulation of cell death by apoptosis. The yeast Two-Hybrid system was utilized to identify a protein that interacts with the anti-apoptotic protein Bcl-2, designated BMRP. This protein corresponds to a previously known mitochondrial ribosomal protein (MRPL41). Binding experiments confirmed the interaction of BMRP to Bcl-2 in mammalian cells. Subcellular fractionation by differential centrifugation studies showed that both Bcl-2 and BMRP are localized to the same fractions (fractions that are rich in mitochondria). Northern blot analysis revealed a major bmrp mRNA band of approximately 0.8 kb in several human tissues. Additionally, a larger 2.2 kb mRNA species was also observed in some tissues. Western blot analysis showed that endogenous BMRP runs as a band of 16-17 kDa in SDS-PAGE. Overexpression of BMRP induced cell death in primary embryonic fibroblasts and NIH/3T3 cells. Transfection of BMRP showed similar effects to those observed by overexpression of the pro-apoptotic proteins Bax or Bad. BMRP-stimulated cell death was counteracted by co-expression of Bcl-2. The baculoviral caspase inhibitor p35 also protected cells from BMRP-induced cell death. These findings suggest that BMRP is a mitochondrial ribosomal protein involved in the regulation of cell death by apoptosis, probably affecting pathways mediated by Bcl-2 and caspases.(C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:611 / 626
页数:16
相关论文
共 50 条
  • [21] Conjugated linoleic acid induces apoptosis of murine mammary tumor cells via Bcl-2 loss
    Ou, Lihui
    IP, Clement
    Lisafeld, Barbara
    Ip, Margot M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 356 (04) : 1044 - 1049
  • [22] Subchronic exposure to arsenic induces apoptosis in the hippocampus of the mouse brains through the Bcl-2/Bax pathway
    Wang, Yachen
    Bai, Canming
    Guan, Huai
    Chen, Ruolin
    Wang, Xiaxu
    Wang, Bingwen
    Jin, Hetian
    Piao, Fengyuan
    JOURNAL OF OCCUPATIONAL HEALTH, 2015, 57 (03) : 212 - 221
  • [23] Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death
    Lee, JH
    Takahashi, T
    Yasuhara, N
    Inazawa, J
    Kamada, S
    Tsujimoto, Y
    ONCOGENE, 1999, 18 (46) : 6183 - 6190
  • [24] Cytological grading, apoptosis, and Bcl-2 protein expression in breast cancer
    Hemachandran, M
    Nijhawan, R
    Joshi, K
    DIAGNOSTIC CYTOPATHOLOGY, 2002, 26 (06) : 356 - 359
  • [25] BCL-2, a novel regulator of apoptosis
    Park, JR
    Hockenbery, DM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 60 (01) : 12 - 17
  • [26] Bcl-2 family proteins and apoptosis
    Fu, YF
    Fan, TJ
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2002, 34 (04): : 389 - 394
  • [27] Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors
    Tateyama, H
    Eimoto, T
    Tada, T
    Inagaki, H
    Hattori, H
    Takino, H
    MODERN PATHOLOGY, 1997, 10 (10) : 983 - 991
  • [28] Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein
    Ji, Y. B.
    Gao, S. Y.
    Ji, C. F.
    Zou, X.
    JOURNAL OF ETHNOPHARMACOLOGY, 2008, 115 (02) : 194 - 202
  • [29] Apoptosis is associated with modifications of bcl-2 mRNA AU-Binding proteins
    Donnini, M
    Lapucci, A
    Papucci, L
    Witort, E
    Tempestini, A
    Brewer, G
    Bevilacqua, A
    Nicolin, A
    Capaccioli, S
    Schiavone, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (05) : 1063 - 1069
  • [30] BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential
    Schimmer, AD
    Hedley, DW
    Pham, NA
    Chow, S
    Minden, MD
    LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 429 - 443